Anti-Tumor Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
(PR Web Via Acquire Media NewsEdge) Albany, New York, USA (PRWEB) April 13, 2014
Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It has been observed that cancer is second leading cause of deaths in Europe and North America. To treat these tumor growth, anti tumor drugs are considered as of one of the key therapy which has been accepted worldwide.
Browse the full report with request TOC at http://www.transparencymarketresearch.com/anti-tumor-drugs-market.html.
Various drugs are used to treat tumors which includes citomycin D, daunorubicin, doxorubicin, bleomycin, epirubicin, mitoxantrone , idarucicin and mitomycin. In addition, various drugs which are alkaloids are also used for the same such as etoposide, irinotecan and docetaxel. The other alkaloids includes topotecan, paclitaxel, vinorelbine, vincristine, vinblastine, bendamustine, streptozocin, temozolomide, chlorambucil, dacarbazine, ifosfamide, busulfan, cyclophosphamide , procarbazine, melphalan and carmustine. All these drugs help in preventing the growth of tumor cells by controlling the level of hormones for these cells.
The incidence of cancer patients has increased significantly which has led to the growth of anti-tumor drugs market. It has been reported by the WHO that global cancer incidence would reach 15 million by 2025 and thus expected to boost the demand of anti-tumor and anti-cancer drugs. In addition, numerous deaths across the globe due to cancer have drawn the concern of Governments and NGOs of various nations towards the development of drugs market growth. Government funding for R&D on these drugs has would also augment the growth of this market owing to rise in demand for number of drugs. Despite all these advantages, various factors such as nausea, vomiting, weakness, hair loss, dermatological side effects and allergies may hamper the growth of this market. Some of the major players in anti-tumor drugs market include Isis pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences and others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
Rest of the World
This report provides comprehensive analysis of:
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter's five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
90 State Street,
Albany NY - 12207
Browse More Market Reports:-
Read the full story at http://www.prweb.com/releases/2014/04/prweb11756481.htm
(c) 2014 PRWEB.COM Newswire
[ Back To Cloud Computing 's Homepage ]